JP2012523416A5 - - Google Patents

Download PDF

Info

Publication number
JP2012523416A5
JP2012523416A5 JP2012504759A JP2012504759A JP2012523416A5 JP 2012523416 A5 JP2012523416 A5 JP 2012523416A5 JP 2012504759 A JP2012504759 A JP 2012504759A JP 2012504759 A JP2012504759 A JP 2012504759A JP 2012523416 A5 JP2012523416 A5 JP 2012523416A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound according
methyl
isobutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012504759A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012523416A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/030038 external-priority patent/WO2010117979A2/en
Publication of JP2012523416A publication Critical patent/JP2012523416A/ja
Publication of JP2012523416A5 publication Critical patent/JP2012523416A5/ja
Pending legal-status Critical Current

Links

JP2012504759A 2009-04-09 2010-04-06 セロトニンおよびノルエピネフリン再取り込み阻害剤 Pending JP2012523416A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16807909P 2009-04-09 2009-04-09
US61/168,079 2009-04-09
PCT/US2010/030038 WO2010117979A2 (en) 2009-04-09 2010-04-06 Serotonin and norepinephrine reuptake inhibitor

Publications (2)

Publication Number Publication Date
JP2012523416A JP2012523416A (ja) 2012-10-04
JP2012523416A5 true JP2012523416A5 (https=) 2013-05-09

Family

ID=42698378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012504759A Pending JP2012523416A (ja) 2009-04-09 2010-04-06 セロトニンおよびノルエピネフリン再取り込み阻害剤

Country Status (14)

Country Link
US (1) US8173821B2 (https=)
EP (1) EP2417124B1 (https=)
JP (1) JP2012523416A (https=)
KR (1) KR101378260B1 (https=)
CN (1) CN102388036A (https=)
AR (1) AR075988A1 (https=)
AU (1) AU2010234610B2 (https=)
BR (1) BRPI1014382A2 (https=)
CA (1) CA2758251C (https=)
EA (1) EA201171230A1 (https=)
ES (1) ES2446644T3 (https=)
MX (1) MX2011010658A (https=)
TW (1) TW201103908A (https=)
WO (1) WO2010117979A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010011811A2 (en) 2008-07-24 2010-01-28 Theravance, Inc. 3-(phenoxyphenylmethyl)pyrrolidine compounds
WO2010120910A1 (en) * 2009-04-15 2010-10-21 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
AU2010273645B2 (en) * 2009-07-13 2014-12-04 Theravance Biopharma R&D Ip, Llc 3-phenoxymethylpyrrolidine compounds
US8273786B2 (en) 2009-07-21 2012-09-25 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
US8471040B2 (en) 2010-10-11 2013-06-25 Theravance, Inc. Serotonin reuptake inhibitors
US8501964B2 (en) 2010-12-03 2013-08-06 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1004346C2 (nl) 1996-10-23 1998-04-24 Dsm Nv Werkwijze voor het scheiden van een mengsel van enantiomeren in een geschikt oplosmiddel.
CA2698384C (en) * 1996-12-10 2012-05-01 Abbott Laboratories 3-pyridyl enantiomers and their use as analgesics
DK1047690T3 (da) 1997-12-19 2004-07-05 Abbott Lab Heterocykliske ether- og thioetherforbindelser, som er anvendelige til regulering af kemisk, synaptisk overförsel
JP2003529547A (ja) 1999-09-14 2003-10-07 アボット・ラボラトリーズ 化学シナプス伝達のコントロールに有効な3−ピロリジニルオキシ−3’−ピリジルエーテル化合物
US20020151712A1 (en) 1999-09-14 2002-10-17 Nan-Horng Lin 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
BRPI0510453A (pt) 2004-04-30 2007-10-30 Warner Lambert Co composto substituìdos com morfolina para o tratamento de distúrbios do sistema nervoso central
EP2066630A1 (en) * 2006-08-23 2009-06-10 Pfizer Products Incorporated Piperidine derivatives
ATE528300T1 (de) 2006-12-06 2011-10-15 Glaxosmithkline Llc Bizyklische verbindungen und ihre verwendung als antidiabetika
WO2010011811A2 (en) 2008-07-24 2010-01-28 Theravance, Inc. 3-(phenoxyphenylmethyl)pyrrolidine compounds

Similar Documents

Publication Publication Date Title
JP2010501534A5 (https=)
JP2012530705A5 (https=)
JP2013530958A5 (https=)
JP2012507535A5 (https=)
JP2014506907A5 (https=)
JP2013032389A5 (https=)
JP2009502743A5 (https=)
JP2013537203A5 (https=)
JP2007302683A5 (https=)
JP2009545527A5 (https=)
JP2012092103A5 (https=)
JP2014515013A5 (https=)
JP2011528658A5 (https=)
JP2013525444A5 (https=)
JP2012255026A5 (https=)
JP2010513478A5 (https=)
JP2013518107A5 (https=)
JP2014507446A5 (https=)
JP2017537066A5 (https=)
JP2014507455A5 (https=)
JP2011518833A5 (https=)
JP2014511891A5 (https=)
JP2015512931A5 (https=)
JP2010523692A5 (https=)
JP2010526777A5 (https=)